Details
Stereochemistry | ACHIRAL |
Molecular Formula | C11H14N2S |
Molecular Weight | 206.307 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1CCCN=C1\C=C\C2=CC=CS2
InChI
InChIKey=YSAUAVHXTIETRK-AATRIKPKSA-N
InChI=1S/C11H14N2S/c1-13-8-3-7-12-11(13)6-5-10-4-2-9-14-10/h2,4-6,9H,3,7-8H2,1H3/b6-5+
DescriptionCurator's Comment: description was created based on several sources, including:
https://www.drugs.com/monograph/pyrantel-pamoate.html
Curator's Comment: description was created based on several sources, including:
https://www.drugs.com/monograph/pyrantel-pamoate.html
Pyrantel is an anthelmintic, which acts as an agonist of nicotinic receptors (AChRs) of nematodes and exerts its therapeutic effects by depolarizing their muscle membranes. It is used to treat a number of parasitic worm infections. This includes ascariasis, hookworm infections, enterobiasis (pinworm infection), trichostrongyliasis and trichinellosis. Common adverse reactions include diarrhea, nausea, vomiting, dizziness, headache and somnolence.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Nicotinic receptors (AChRs) of nematodes |
|||
Target ID: Mouse α2βεδ AChRs Sources: https://www.ncbi.nlm.nih.gov/pubmed/11489460 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | Strongid Approved UseDrug is indicated for the removal and control of mature infections of large strongyles (Strongylus vulgaris, S. edentatus, S. equinus); small strongyles; pinworms (Oxyuris equi); and large roundworms (Parascaris equorum) in horses and ponies. Launch Date1990 |
|||
Curative | Strongid Approved UseDrug is indicated for the removal and control of mature infections of large strongyles (Strongylus vulgaris, S. edentatus, S. equinus); small strongyles; pinworms (Oxyuris equi); and large roundworms (Parascaris equorum) in horses and ponies. Launch Date1990 |
|||
Curative | Strongid Approved UseDrug is indicated for the removal and control of mature infections of large strongyles (Strongylus vulgaris, S. edentatus, S. equinus); small strongyles; pinworms (Oxyuris equi); and large roundworms (Parascaris equorum) in horses and ponies. Launch Date1990 |
|||
Curative | Strongid Approved UsePyrantel pamoate is indicated for the removal and control of mature infections of large strongyles (Strongylus vulgaris, S. edentatus, S. equinus); small strongyles; pinworms (Oxyuris equi); large roundworms (Parascaris equorum) and tapeworms (Anoplocephala perfoliata) in horses and ponies. Launch Date1990 |
Cmax
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
0.09 μg/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/11348490/ |
13.3 mg/kg single, oral dose: 13.3 mg/kg route of administration: Oral experiment type: SINGLE co-administered: |
PYRANTEL plasma | Equus caballus population: HEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN |
AUC
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
1.06 μg × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/11348490/ |
13.3 mg/kg single, oral dose: 13.3 mg/kg route of administration: Oral experiment type: SINGLE co-administered: |
PYRANTEL plasma | Equus caballus population: HEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN |
T1/2
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
13.43 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/11348490/ |
13.3 mg/kg single, oral dose: 13.3 mg/kg route of administration: Oral experiment type: SINGLE co-administered: |
PYRANTEL plasma | Equus caballus population: HEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16725288
A modified methyl-thiazolyltetrazolium (MTT) reduction assay revealed good in vitro anthelmintic efficacies against Haemonchus contortus infective larvae for pyrantel tartrate at effective dose 0.1 ug/ul – 0.9 ug/ul.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 520.1871
Created by
admin on Wed Apr 02 08:21:11 GMT 2025 , Edited by admin on Wed Apr 02 08:21:11 GMT 2025
|
||
|
WHO-VATC |
QP52AF02
Created by
admin on Wed Apr 02 08:21:11 GMT 2025 , Edited by admin on Wed Apr 02 08:21:11 GMT 2025
|
||
|
CFR |
21 CFR 520.1196
Created by
admin on Wed Apr 02 08:21:11 GMT 2025 , Edited by admin on Wed Apr 02 08:21:11 GMT 2025
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.1.1
Created by
admin on Wed Apr 02 08:21:11 GMT 2025 , Edited by admin on Wed Apr 02 08:21:11 GMT 2025
|
||
|
LIVERTOX |
NBK548238
Created by
admin on Wed Apr 02 08:21:11 GMT 2025 , Edited by admin on Wed Apr 02 08:21:11 GMT 2025
|
||
|
WHO-ATC |
P02CC01
Created by
admin on Wed Apr 02 08:21:11 GMT 2025 , Edited by admin on Wed Apr 02 08:21:11 GMT 2025
|
||
|
NCI_THESAURUS |
C250
Created by
admin on Wed Apr 02 08:21:11 GMT 2025 , Edited by admin on Wed Apr 02 08:21:11 GMT 2025
|
||
|
CFR |
21 CFR 520.1199
Created by
admin on Wed Apr 02 08:21:11 GMT 2025 , Edited by admin on Wed Apr 02 08:21:11 GMT 2025
|
||
|
CFR |
21 CFR 558.485
Created by
admin on Wed Apr 02 08:21:11 GMT 2025 , Edited by admin on Wed Apr 02 08:21:11 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
239-774-1
Created by
admin on Wed Apr 02 08:21:11 GMT 2025 , Edited by admin on Wed Apr 02 08:21:11 GMT 2025
|
PRIMARY | |||
|
4QIH0N49E7
Created by
admin on Wed Apr 02 08:21:11 GMT 2025 , Edited by admin on Wed Apr 02 08:21:11 GMT 2025
|
PRIMARY | |||
|
DTXSID5023538
Created by
admin on Wed Apr 02 08:21:11 GMT 2025 , Edited by admin on Wed Apr 02 08:21:11 GMT 2025
|
PRIMARY | |||
|
Pyrantel
Created by
admin on Wed Apr 02 08:21:11 GMT 2025 , Edited by admin on Wed Apr 02 08:21:11 GMT 2025
|
PRIMARY | |||
|
CHEMBL1626223
Created by
admin on Wed Apr 02 08:21:11 GMT 2025 , Edited by admin on Wed Apr 02 08:21:11 GMT 2025
|
PRIMARY | |||
|
2228
Created by
admin on Wed Apr 02 08:21:11 GMT 2025 , Edited by admin on Wed Apr 02 08:21:11 GMT 2025
|
PRIMARY | |||
|
C75231
Created by
admin on Wed Apr 02 08:21:11 GMT 2025 , Edited by admin on Wed Apr 02 08:21:11 GMT 2025
|
PRIMARY | |||
|
PYRANTEL
Created by
admin on Wed Apr 02 08:21:11 GMT 2025 , Edited by admin on Wed Apr 02 08:21:11 GMT 2025
|
PRIMARY | |||
|
8654
Created by
admin on Wed Apr 02 08:21:11 GMT 2025 , Edited by admin on Wed Apr 02 08:21:11 GMT 2025
|
PRIMARY | |||
|
m9336
Created by
admin on Wed Apr 02 08:21:11 GMT 2025 , Edited by admin on Wed Apr 02 08:21:11 GMT 2025
|
PRIMARY | Merck Index | ||
|
100000080865
Created by
admin on Wed Apr 02 08:21:11 GMT 2025 , Edited by admin on Wed Apr 02 08:21:11 GMT 2025
|
PRIMARY | |||
|
2999
Created by
admin on Wed Apr 02 08:21:11 GMT 2025 , Edited by admin on Wed Apr 02 08:21:11 GMT 2025
|
PRIMARY | |||
|
3252
Created by
admin on Wed Apr 02 08:21:11 GMT 2025 , Edited by admin on Wed Apr 02 08:21:11 GMT 2025
|
PRIMARY | |||
|
D011715
Created by
admin on Wed Apr 02 08:21:11 GMT 2025 , Edited by admin on Wed Apr 02 08:21:11 GMT 2025
|
PRIMARY | |||
|
DB11156
Created by
admin on Wed Apr 02 08:21:11 GMT 2025 , Edited by admin on Wed Apr 02 08:21:11 GMT 2025
|
PRIMARY | |||
|
15686-83-6
Created by
admin on Wed Apr 02 08:21:11 GMT 2025 , Edited by admin on Wed Apr 02 08:21:11 GMT 2025
|
PRIMARY | |||
|
4QIH0N49E7
Created by
admin on Wed Apr 02 08:21:11 GMT 2025 , Edited by admin on Wed Apr 02 08:21:11 GMT 2025
|
PRIMARY | |||
|
8984
Created by
admin on Wed Apr 02 08:21:11 GMT 2025 , Edited by admin on Wed Apr 02 08:21:11 GMT 2025
|
PRIMARY | RxNorm | ||
|
708857
Created by
admin on Wed Apr 02 08:21:11 GMT 2025 , Edited by admin on Wed Apr 02 08:21:11 GMT 2025
|
PRIMARY | |||
|
SUB10162MIG
Created by
admin on Wed Apr 02 08:21:11 GMT 2025 , Edited by admin on Wed Apr 02 08:21:11 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)